Phoenix-based Planatome®, an innovator of disruptive medical devices, leveraging atomic-level polishing from the semiconductor industry, announced a new partnership with Medikana to create distribution throughout Central and South America. Already yielding success within Venezuela, the Dominican Republic, and Panama, this agreement extends Planatome’s revolutionary scalpel blade technology across a surgically booming Latin American region.
“Our partnership with Medikana is a solid foothold in furthering our mission of improving the lives of others, particularly for patients at risk of adverse healing events such as keloid and hypertrophic scarring,” said Tim Tobin, Planatome’s CEO. “Medikana’s robust network and expertise in the Latin American market lands squarely on this critical patient demographic and will be invaluable as we work to provide surgeons and their patients with extraordinary surgical outcomes.”
This distribution agreement reflects Planatome’s commitment to setting a new standard in patient care. The partnership with Medikana underscores our shared vision of making advanced healthcare solutions accessible across key regions in Latin America.
“We are thrilled to partner with Planatome, a truly innovative company that is setting new standards in surgical technology. This collaboration aligns perfectly with Medikana’s mission to enhance access to cutting-edge medical solutions across Latin America. Together, we are proud to bring Planatome’s low-trauma surgical blades to thousands of patients, supporting faster healing and better outcomes, advancing the quality of care throughout the region. This partnership is just the beginning of our shared journey to transform healthcare in LATAM,” said Corina Negron, CEO of Medikana.
Speak Your Mind
You must be logged in to post a comment.